Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT02746237
Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2015
Completion: Aug 31, 2016